In vitro localization of human neural stem cell neurogenesis by engineered FGF-2 gradients

Area of Science:

• Neuroscience
• Developmental Biology
• Biotechnology

Background:

• Effective stem cell therapies for brain disorders require generating specific neural cell types and organizing them into functional tissues.
• Cerebral cortex development involves intercellular signaling between proliferative and neurogenic regions, but key factors remain unknown.
• Fibroblast growth factor 2 (FGF-2) is present in developmental gradients and influences neural stem cell proliferation and neurogenesis.

Purpose of the Study:

• To investigate if fibroblast growth factor 2 (FGF-2) gradients can establish distinct proliferation and neurogenesis regions in human neural stem cell (hNSC) cultures using microfluidics.
• To explore the impact of FGF-2 concentration gradients on neural cell differentiation and organization in a 3D hydrogel system.

Main Methods:

• Adapted a microfluidic approach to create stable, controlled concentration gradients of FGF-2 within 3D hydrogels.
• Cultured human neural stem cells (hNSCs) within these FGF-2 gradients (0-2 ng mL(-1)) to assess proliferation and neurogenesis.
• Quantified the percentage of TuJ1(+) neurons and the localization of dividing hNSCs and progenitors under gradient conditions.

Main Results:

• Exponential FGF-2 gradients, but not linear ones, significantly increased the percentage of TuJ1(+) neurons in lower concentration areas compared to controls.
• No gradient-dependent localization was observed for dividing hNSCs or their derived intermediate progenitors.
• The study demonstrated that exponential FGF-2 gradients can promote asymmetric neuron generation in vitro.

Conclusions:

• Exponential FGF-2 gradients are effective in generating asymmetric neuron cultures, suggesting a role in vivo for establishing neuronal distribution in the developing cerebral cortex.
• While useful for neuron generation, FGF-2 gradients alone are insufficient to fully replicate the complex signaling of the ventricular zone niche.
• Further research is needed to identify additional factors that, in conjunction with FGF-2, can recapitulate the in vivo neural stem cell niche for advanced regenerative therapies.